- Home
- RAPT vs KODK Comparison
RAPT vs KODK Comparison
Compare RAPT & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- KODK
- Stock Information
- Founded
- RAPT 2015
- KODK 1880
- Country
- RAPT United States
- KODK United States
- Employees
- RAPT N/A
- KODK N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- KODK Business Services
- Sector
- RAPT Health Care
- KODK Consumer Discretionary
- Exchange
- RAPT Nasdaq
- KODK Nasdaq
- Market Cap
- RAPT 498.4M
- KODK 476.6M
- IPO Year
- RAPT 2019
- KODK N/A
- Fundamental
- Price
- RAPT $28.83
- KODK $7.45
- Analyst Decision
- RAPT Strong Buy
- KODK
- Analyst Count
- RAPT 9
- KODK 0
- Target Price
- RAPT $57.00
- KODK N/A
- AVG Volume (30 Days)
- RAPT 778.5K
- KODK 1.8M
- Earning Date
- RAPT 11-06-2025
- KODK 11-06-2025
- Dividend Yield
- RAPT N/A
- KODK N/A
- EPS Growth
- RAPT N/A
- KODK N/A
- EPS
- RAPT N/A
- KODK N/A
- Revenue
- RAPT N/A
- KODK $1,045,000,000.00
- Revenue This Year
- RAPT N/A
- KODK N/A
- Revenue Next Year
- RAPT N/A
- KODK N/A
- P/E Ratio
- RAPT N/A
- KODK N/A
- Revenue Growth
- RAPT N/A
- KODK N/A
- 52 Week Low
- RAPT $5.67
- KODK $4.26
- 52 Week High
- RAPT $42.39
- KODK $8.90
- Technical
- Relative Strength Index (RSI)
- RAPT 53.26
- KODK 54.72
- Support Level
- RAPT $27.76
- KODK $5.78
- Resistance Level
- RAPT $29.90
- KODK $8.90
- Average True Range (ATR)
- RAPT 1.66
- KODK 0.56
- MACD
- RAPT -0.46
- KODK 0.15
- Stochastic Oscillator
- RAPT 41.72
- KODK 51.20
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About KODK Eastman Kodak Company Common New
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.